Showing results (71-80 of 2,066) with videos related to
Sort By:
Pageof 207
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15B Fisher, A M Brown, N V Dimitrov, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16B Fisher, C Redmond, S Legault-Poisson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17B Fisher, J Dignam, N Wolmark, et al.The New England Journal of Medicine|January 16, 1975
L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findingsB Fisher, P Carbone, S G Economou, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Meta-Analysis Group in CancerP Thirion, N Wolmark, E Haddad, et al.JAMA|November 17, 2001
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention TrialM C King, S Wieand, K Hale, et al.Journal of the National Cancer Institute|December 5, 1998
Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05N Wolmark, J Bryant, R Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04N Wolmark, H Rockette, E Mamounas, et al.Journal of the National Cancer Institute|December 9, 1997
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancerB Fisher, J Dignam, N Wolmark, et al.Cryobiology|August 25, 1999
Long-term follow-up post-cryosurgery in a sheep breast modelY Rabin, T B Julian, P Olson, et al.Pageof 207